Tel: +263 242 708020, +263 242 705946 info@uzchsrsc.ac.zw

Funding Opportunities

Nestlé Foundation Research Grants

The Nestlé Foundation offers different award and grant categories, some of them using a modular approach, i.e. the Pilot Grant Program represents the starting grant module for a later Full Grant Research application. The eligibility criteria as well as the Research objectives and topics have to be fulfilled independently from the award category (for further details see section “Specific information for applications”):

  1. Training Grant
  2. Pilot Grant
  3. Full Grant (small / large)

At present the Foundation’s work is primarily concerned with human nutrition research issues dealing with:

  • maternal and child nutrition, including breastfeeding and complementary feeding,
  • macro- and micronutrient deficiencies and imbalances,
  • interactions between infection and nutrition, and
  • nutrition education and health promotion.

Due date for Letter of Intent: N/A

For more information click; https://www.nestlefoundation.org/research.html

 

Global Health Research – Researcher-led bands 1 to 3

Our Global Health Research (GHR) – Researcher-led programmes are looking for applications to this new, annual funding opportunity. GHR – Researcher-led funds research that aims to improve health outcomes for the most vulnerable people in low and middle income countries (LMICs). Research must address evidence needs that are locally identified and prioritised, and must promote health equity, aligning with the aims of Sustainable Development Goal 3. Applications can span from broad, ambitious programmes of research to projects with a narrower scope. This is a two-stage funding opportunity.

Due date: 6 November 2024 at 1:00 pm

Award budget: £0.25-£7 million, over a period up to 5 years, depending on the band you apply for.

For more information click: https://www.nihr.ac.uk/funding/global-health-research-researcher-led-bands-1-3/97010

 

Call for Proposals: TANGO2 Research Foundation Grant Program

The TANGO2 Research Foundation (T2RF) research grants provide essential funding for seed or pilot research projects, fostering the exploration of groundbreaking research concepts. These awards support initial testing phases, allowing researchers to embark on smaller-scale endeavors. The emphasis lies in evaluating feasibility and refining methodologies, shaping the trajectory of potential larger-scale studies. Through this funding mechanism, we empower researchers to take innovative ideas from conception to a vital stage of validation, contributing to the advancement of knowledge and discovery. We seek to fund rigorous, high-quality research studies in efforts to fulfill our foundation’s mission enthusiastically.

Letter of Intent Due date: 8 November 2024

Award budget: Up to $25,000 for single institution & up to $50,000 for multi-institution (with an opportunity for up to an additional $25,000 with a competitive one year renewal)

For more information click: https://tango2research.org/research/grants/

 

Global Call for Collaborators – Pfizer Migraine Research 

Globally, there are more than one billion people living with migraine and it ranks among the top three most debilitating neurological diseases. While research into the etiology and treatment of migraine continues to advance, key knowledge gaps remain. The intent of this CFC is to identify investigators with innovative research ideas who want to partner and co-develop research studies with Pfizer, and potentially other investigators where multiple proposals share similar objectives and methodological approaches. In these instances, Pfizer along with the investigators, may pursue a single research study with multiple sites should all the parties agree. This CFC will be a two step process. The first step will be for investigators to submit a  Letter of Intent (LOI)  providing a high-level synopsis of the proposed project. In the second step, LOIs will be selected for further development into a research collaboration with Pfizer.

Due date: 13 November 2024 23:59 Eastern Standard Time

Award budget: $500,000

For more information click: chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://cdn.pfizer.com/pfizercom/2024-10/Global%20CFC%20%E2%80%93%20Pfizer%20Migraine%20Research%20-%20October%202024.pdf?VersionId=P2Ud8mbnCVpjKF6N3UjAsR3lHubWh89r

 

GenScript Life Science Research Grant Program

GenScript Life Science Research Grant Program is a new initiative dedicated to supporting breakthroughs in life science research areas, including but not limited to those indicated below. This program is designed to empower researchers by providing grant funding earmarked explicitly for purchasing GenScript reagents and services.

  • Gene and Cell Therapy Development
  • Antibody Drug Discovery
  • Vaccine Development

Deadline: 15 November 2024

For more information click: https://www.genscript.com/grantprogram.html

 

Wellcome Career Development Awards

This scheme provides funding for mid-career researchers from any discipline who have the potential to be international research leaders. They will develop their research capabilities, drive innovative programmes of work and deliver significant shifts in understanding related to human life, health and wellbeing.

Due date: 24 November 2024

Award budget: The annual expenditure for a Career Development Award is usually below £250,000 excluding the applicant’s salary.

For more information click: https://wellcome.org/grant-funding/schemes/career-development-awards

 

Wellcome Discovery Awards

This scheme provides funding for established researchers and teams from any discipline who want to pursue bold and creative research ideas to deliver significant shifts in understanding related to human life, health and wellbeing.

Due date: 3 December 2024

Award budget: The average size of a Discovery Award is £3.5 million.

For more information click: https://wellcome.org/grant-funding/schemes/discovery-awards

Applied global health research: stage one

Apply for funding to support applied research that will address global health challenges and inequities.

We will accept applications of all sizes, including large research projects and small to medium-scale applications. We are looking to develop a portfolio of high-quality global research which will be diverse, promote multidisciplinarity and strengthen global health research capacity.
We encourage applications from project leads based in:

  • low and middle-income countries (LMICs)
  • UK, working in equitable partnership with LMIC researchers

Due date: 3 December 2024 4:00pm UK time

Award budget: £150,000 – £2,000,000

For more information click: https://www.ukri.org/opportunity/applied-global-health-research/

Gastrointestinal Manifestations of CF: Basic Science Projects

The intent of this request for applications is to solicit and fund projects that will improve our understanding of the biological basis for the development and progression of gastrointestinal manifestations in cystic fibrosis as well as to identify potential novel therapeutic strategies to manage and treat them. Grant applications submitted through this request for applications (RFA) must focus on basic science research projects. Proposals that include methodologies requiring human subjects or sampling of materials from human subjects will be considered under this mechanism only if the sampling method constitutes minimal patient risk (e.g., venipuncture, nasal brushings) and the sample will be utilized in basic or laboratory research. Projects using previously obtained human samples or samples collected as part of routine clinical care may be allowed; however, this should be specified clearly in the application.

Due date: 5 December 2024  5 p.m. ET

Award budget: The CF Foundation offers funding of up to $150,000 per year for up to three years

For more information click: https://www.cff.org/researchers/gastrointestinal-manifestations-cf-basic-science-projects

 

Mental Health Award: Accelerating scalable digital mental health interventions

This call will fund research to evaluate and further develop scalable digital interventions to advance early intervention in depression, anxiety and psychosis. Teams must have the research expertise required to drive the proposed research, an organisation which can take the intervention to scale (whether a company or not-for-profit) and lived experience experts. This call is open to interventions designed to lead to reductions in symptom(s) and/or functional impairments related to anxiety, depression or psychosis. We expect teams to already have a minimum viable product and feasibility data for their intervention.

Due date: 5 December 2024

Award budget: £3 to 7 million per project

For more information click: https://wellcome.org/grant-funding/schemes/digital-mental-health-interventions

HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Institutions (R21 Clinical Trial Optional)

The goals of this program are to support locally relevant research in critical areas of HIV-associated non-communicable diseases (NCDs) at Low- and Middle-Income Country (LMIC) Institutions, to enhance research capacity, and to build a network of researchers both within and across LMICs to address this critical burden. This initiative is expected to stimulate new research on the interplay between HIV and development of NCDs in persons living with HIV (PLWH). This includes exploratory studies to uncover the extent to which HIV infection influences the etiopathogenesis of the NCDs; and to identify and develop appropriate approaches for effective diagnosis, prevention, therapeutic interventions and integrated clinical care for PLWH with the comorbid conditions. Applicants should develop their studies in keeping with the NIH HIV/AIDS Research Priorities

(https://www.oar.nih.gov/hiv-policy-and-research/research-priorities;

https://grants.nih.gov/grants/guide/notice-files/NOT-OD-20-018.html). Research teams should contain an appropriate mix of expertise to accomplish the proposed studies, including partnerships between HIV and NCD researchers who can initiate new ideas, and determine feasibility of novel approaches to understand and reduce the long-term suffering from the comorbid disorders. Applicants will also be asked to address the needs of collaborating LMIC institutions to develop capacity for carrying out research in this field.

Deadline: 9 December 2024

Award budget: The combined budget for direct costs for the two-year project period may not exceed $275,000. No more than $150,000 may be requested in any single year.

For more information click: https://grants.nih.gov/grants/guide/pa-files/PAR-23-191.html

The Confluence of Cancer Stigma and HIV Stigma in HIV-positive Individuals Diagnosed with Cancer (R21 Clinical Trial Optional)

Through this notice of funding opportunity (NOFO) as a request for applications (RFA), the National Cancer Institute (NCI) intends to support pilot/exploratory research that expands the current understanding of the confluence of cancer stigma and HIV stigma in people with HIV (PWH) diagnosed with cancer; assesses the impact of these two converging stigmas on cancer outcomes among PWH with cancer; leverages stigma reduction interventions at multiple levels to intervene on modifiable mechanisms of stigma that contribute to negative cancer outcomes among PWH with cancer; and promotes research in domestic and international contexts, focusing on regions in which the HIV-cancer burden is elevated.

Due date: 10 December 2024

Award budget: R21 applications are limited to $275,000 in direct costs for up to 2 years. No more than $200,000 may be requested in any single year.

For more information click: https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-25-012.html

 

The Confluence of Cancer Stigma and HIV Stigma in HIV-positive Individuals Diagnosed with Cancer (R01 Clinical Trial Optional)

Through this notice of funding opportunity (NOFO) as a request for applications (RFA), the National Cancer Institute (NCI) intends to support research that expands the current understanding of the confluence of cancer stigma and HIV stigma among people with HIV (PWH) diagnosed with cancer; assesses the impact of these two converging stigmas on cancer outcomes among PWH with cancer; leverages stigma reduction interventions at multiple levels to intervene on modifiable mechanisms of stigma that contribute to negative cancer outcomes among PWH with cancer; and promotes research in domestic and international contexts, focusing on regions in which the HIV-cancer burden is elevated.

Due date: 10 December 2024

Award budget: Direct costs in any single year should reflect the actual needs of the proposed project; however, budgets are limited to $500,000 Direct Costs (excluding consortium F&A) per year.

For more information click: https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-25-011.html

 

Melvin Yahr Parkinson’s Disease Clinical Research Award

The Parkinson’s Foundation is seeking proposals for its Melvin Yahr Parkinson’s Disease Clinical Research Award to foster clinical research into any aspect of Parkinson’s disease conducted by young investigators who are under-represented in current research. The goal of the award is to prepare young neurologists specializing in Parkinson’s disease for a career in clinical research. Clinician scientists are uniquely positioned to be experts in both Parkinson’s disease research and care.

Due date: 9 January 2025

Award budget: This is a 1-year award for a total of $50,000.

For more information click: https://www.parkinson.org/resources-support/professionals/resources/clinical-training-awards#PartnershipAwards

 

E.W. “Al” Thrasher Awards

E.W. “Al” Thrasher Awards focus on projects that are changing pediatric clinical care. Each award is a novel approach to problems plaguing pediatrics. The award is open to applications focusing on any disease or topic within the umbrella of pediatrics, both in and outside the United States.

Ideal applications for the Thrasher Award address significant health problems, offering the potential for practical solutions to these problems. Typically, the primary outcome is a health outcome in children. Solutions should be innovative and have the potential for broad applicability with low barriers to implementation. Projects with a shorter distance to clinical applicability are given priority. Hypothesis-driven research is critical, exploratory, or hypothesis-generating research will not be competitive.

For projects focused on improving disease diagnosis, please ensure that there are well researched, effective treatment options available to patients upon diagnosis.

Concept Due date: January 14, 2025 (Noon Mountain Time)

Award budget: The grant amount is based on the actual budgetary needs of the project. Grants are not given over $550,000.

For more information click: https://www.thrasherresearch.org/al-thrasher-award?lang=eng

 

Climate and Mental Health Award: Uncovering mechanisms between heat and mental health

This award will fund projects to advance our understanding of the biological, psychological and/or social mechanisms through which heat affects anxiety, depression and psychosis in the most impacted groups globally. Successful applications will identify relevant climate-resilient and/or mental health interventions with a realistic potential for real-world application.

Due date: 21 January 2025 17:00 (GMT)

Award budget: £1 – 3 million per project

For more information click: https://wellcome.org/grant-funding/schemes/heat-and-mental-health-award#key-dates-e140

 

Consortium for Neuroscience AD/ADRD in Low- and Middle-Income Countries (U01 Clinical Trial Not Allowed)

This Notice of Funding Opportunity (NOFO) aims to promote collaborative research programs by inviting applications to support innovative and sustainable Alzheimer’s disease (AD) and AD-related dementias (ADRD) (including frontotemporal dementia (FTD), Lewy body dementia (LBD), vascular cognitive impairment/dementia (VCID), and mixed etiology dementias (MEDs)) neuroscience research for experienced investigators in low- and middle-income countries (LMICs). These collaborative research programs are expected to contribute to the long-term goals of building sustainable AD/ADRD neuroscience capacity and research, ultimately leading to prevention and mitigation strategies for AD/ADRD in LMICs. This NOFO supports applications submitted from LMIC institutions as defined by the World Bank. LMIC scientists are expected to collaborate with scientists from the United States.

Due date: 14 February 2025

Award budget: Application budgets are limited to $400,000 in direct cost per year.

For more information click: https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-25-032.html

Small Research Grant Program for the Next Generation of Researchers in Low- and Middle-Income Countries (LMICs) for Aging and Alzheimer’s Disease (AD) and AD-Related Dementias (ADRD) Research (R03 Clinical Trial Not Allowed)

This Notice of Funding Opportunity (NOFO) invites R03 applications from institutions in low- and middle-income countries (LMICs), as defined by the World Bank, to support junior faculty investigators involved in aging and Alzheimer’s Disease (AD) and AD-related dementias (ADRD) from these institutions. The goals of this NOFO are the following::

  1. To support the aging and/or AD/ADRD research conducted by junior faculty investigators from institutions in LMICs; and
  2. To support the career development of junior faculty investigators from institutions in LMICs as future leaders in aging and AD/ ADRD.

In support of the program’s goals, this NOFO invites applications that will yield pilot data, resources, and experience for subsequent aging and AD/ADRD research projects. In addition, candidates are encouraged to seek out a supportive research environment that will achieve the goal of fostering the career development of junior investigators.

Due date: 14 February 2025

Award budget: Application budgets are limited to $100,000 in direct cost per year.

For more information click: https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-25-031.html

 

Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)

The purpose of this Funding Opportunity Announcement (FOA) is to support studies that will identify, develop, and/or test strategies for overcoming barriers to the adoption, adaptation, integration, scale-up, and sustainability of evidence-based interventions, practices, programs, tools, treatments, guidelines, and policies. Studies that promote equitable dissemination and implementation of evidence-based interventions among underrepresented communities are encouraged. Conversely, there is a benefit in understanding circumstances that create a need to stop or reduce (“de-implement”) the use of practices that are ineffective, unproven, low-value, or harmful. In addition, studies to advance dissemination and implementation research methods and measures are encouraged. Applications that focus on re-implementation of evidence-based health services (e.g. cancer screening) that may have dropped off amidst the ongoing COVID pandemic are encouraged.

Due dates: 16 February 2025

Award budget: The combined budget for direct costs for the two-year project period may not exceed $275,000. No more than $200,000 may be requested in a single year.

For more information click: https://grants.nih.gov/grants/guide/pa-files/PAR-22-109.html

Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)

The purpose of this Funding Opportunity Announcement (FOA) is to support studies that will identify, develop, and/or test strategies for overcoming barriers to the adoption, adaptation, integration, scale-up, and sustainability of evidence-based interventions, practices, programs, tools, treatments, guidelines, and policies. Studies that promote equitable dissemination and implementation of evidence-based interventions among underrepresented communities are encouraged. Conversely, there is a benefit in understanding circumstances that create a need to stop or reduce (“de-implement”) the use of practices that are ineffective, unproven, low-value, or harmful. In addition, studies to advance dissemination and implementation research methods and measures are encouraged. Applications that focus on re-implementation of evidence-based health services (e.g. cancer screening) that may have dropped off amidst the ongoing COVID pandemic are encouraged.

Due date: 16 February 2025

Award budget: A budget for direct costs of up to $50,000 per year may be requested.

For more information click: https://grants.nih.gov/grants/guide/pa-files/PAR-22-106.html

Fellowships

AAUW International Fellowships

International Fellowships have been in existence since 1917. The program provides support for women pursuing full-time graduate or postdoctoral study in the United States to women who are not U.S. citizens or permanent residents, and who intend to return to their home country to pursue a professional career.

Due date: November 15, 2024, by 11:59 p.m. Pacific Standard Time

Award budget: US$20,000 – $50,000

For more information click: https://www.aauw.org/resources/programs/fellowships-grants/international/

 

Mawazo Fellowship Programme

The Mawazo Fellowship Programme is a 15-month, non-residential fellowship. This programme is designed to build a network of African women experts who are poised to influence policy and public discourse in academia and beyond, increasing the application and implementation of practical, evidence-based ideas that drive Africa’s development.

Due date: 10 November 2024, 11.59 pm EAT

For more information click: https://mawazoinstitute.org/fellowship

2025 Fellowship applications are now open

Applications for the 2025 Ibrahim Leadership Fellowship are now open. The Ibrahim Leadership Fellowships are a 12-month programme designed to support the professional development of future African leaders. The Fellowship programme invites emerging leaders from across Africa to apply to join the 2025 cohort of MIF Fellows and make the most of this opportunity. The Ibrahim Leadership Fellowship is a flagship initiative of the Foundation that equips Fellows with technical and leadership skills and enables them to contribute directly to research and policy design at their host institutions. Past MIF Fellows come from a wide range of backgrounds, including research and advisory work in economics, trade, development, peace studies and conflict resolution. The programme aims to drive positive change and ignite innovation across Africa by providing the next generation of African leaders with practical work experience at renowned international institutions.

Due date: 20 November 2024

For more information click: https://mo.ibrahim.foundation/news/2024/2025-fellowship-applications-now-open

WomenLift Health 2025 Southern Africa Leadership Journey

This 12-month, fully-funded program empowers women to explore their authentic leadership through vulnerability and self-reflection. Participants will build inclusive and diverse networks that foster belonging, learn strategies to enhance their voice, presence, and influence, and receive support from peers, mentors, and coaches. The Leadership Journey equips participants with contextualised tools and frameworks to address individual, organisational, and societal challenges that women leaders in global health face today.

Our Signature Leadership Journey is a transformative learning experience that brings together mid- to senior-career women from various disciplines and sectors in health. It aims to instill the mindset shift needed to address the complex challenges of global public health issues today.

This program is particularly suited for women leaders who value diversity, equity, and inclusion; who recognise the importance of integrating diverse perspectives into policy and practice; and who are eager to expand their leadership presence and influence while paying it forward to others in their organisations.

Due date: 22 November 2024 at 17:00, CAT.

For more information, click: https://www.womenlifthealth.org/southern-africa-signature-leadership-journey/

Webinar

 

Two-Part Virtual Event, NIH Grants Process Primer: Application to Award

NIH is hosting a two-part event that will provide participants with the basics to help you in your role working with the NIH grants process from application preparation to award. In Part One NIH experts will introduce participants to the NIH as an organization, key components of finding the right funding opportunity, the NIH team, application, and more. In Part Two participants will have the opportunity to view demos and engage during this next-level look at tools and systems used during the application process.

Virtual event dates: November 13-14, 2024 at 1:00-4:00 pm ET

To register, click; https://grants.nih.gov/news-events/calendar-of-events/66eaef67c35c99ed5b024512

For Expired funding opportunities:

  Click here

CONTACT US

University of Zimbabwe
Faculty of Medicine and Health Sciences
Research Management Unit
Parirenyatwa Hospital Grounds

Tel: +263 242 708020, +263 242 705946

Email address

rscsacoreoffice@gmail.com

rsc@medsch.uz.ac.zw

Website

www.uzchsrsc.ac.zw

 Twitter

ttps://twitter.com/UZCHSRSC

Linkedin

https://www.linkedin.com/in/uz-fmhs-research-support-centre-995768267/

Research Management       Unit